logo
UK households told to close windows for next 4 weeks to deter one terrifying visitor

UK households told to close windows for next 4 weeks to deter one terrifying visitor

Daily Record16 hours ago
It's the time of year when an unwanted guest may be looking to get into your home
Spiders in the house are part and parcel of the summer months. But August is when false widows, considered the most venomous arachnid in the UK, are on the march and experts have urged householders to act.

The huge spiders, which can bite and dish out pain comparable to a wasp sting, are in their annual mating season march indoors as they search for warm corners.

And homeowners have been urged to close all windows day and night to keep them out. Although they will only bite if they feel threatened, it can result in painful swelling at the site.

In more serious cases, some people can experience an allergic reaction to their venom.
The NHS advises calling 999 and asking for an ambulance if you experience any of the following symptoms from a bite (from any spider or insect):
Lips, mouth, throat or tongue suddenly become swollen
Wheezing or difficulty breathing
Skin, tongue or lips turn blue, grey or pale
You suddenly become very confused, drowsy or dizzy
Fainting
A child is limp, floppy or not responding like they normally do

Three species of false widow spiders are very similar, according to The Wildlife Trusts, and all can be found around the home at this time of year.
There's the Rabbit hutch spider (Steatoda bipunctata), the Cupboard spider (Steatoda grossa) and the Noble false widow spider (Steatoda nobilis).

The noble false widow is the largest of the three, with females growing up to 14mm in body length (10mm for males).
Leading arachnologist Dr Tom Elwood has some tips to keeping the spiders, which belong to the same family as the deadly Black Widow spider, away, reports The Express.

Dr Elwood said: 'August is when male spiders become active. They're searching for a mate and they'll wander through open windows, up walls, into bathtubs — anywhere they can."
Dr Elwood says it's not only open windows that draw spiders in — it's the dust and debris found on many window sills and frames.

"Spiders are drawn to dust, insect remains and debris on window frames," he explains. "Webs cling better to rough or grimy surfaces. That's why cleaning your windows is just as important as keeping them shut."
These spiders are often reported on floors, along skirting boards and up walls.
'Spiders are drawn to dust, insect remains and debris on window frames,' he explains. 'Webs cling better to rough or grimy surfaces. That's why cleaning your windows is just as important as keeping them shut.'

These spiders are often reported on floors, along skirting boards and up walls.
How to keep False Widows out:
Dr Elwood says: 'Do the right things now, and you won't be waking up to spiders crawling across your bedroom floor.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'My seatbelt saved my life - but I wasn't even involved in a car crash'
'My seatbelt saved my life - but I wasn't even involved in a car crash'

Daily Mirror

time6 minutes ago

  • Daily Mirror

'My seatbelt saved my life - but I wasn't even involved in a car crash'

Natalie Deakin, from Nuneaton, Warwickshire, says she is "really grateful" for her car's seatbelt - because she believes it helped her spot a key symptom of her stage-two Hodgkin Lymphoma A mum says her car seatbelt for saving her life - as the "'irritating" strap led her to discover a cancerous lump hidden in her neck. ‌ When the device began causing Natalie Deakin discomfort on her drive home from the weekly shop, she tried to readjust its position. However, the 34-year-old woman felt a hard lump on the right side of her neck. ‌ And so the mum of two immediately booked an appointment with her GP who ordered a series of tests on the golf ball-sized mass. A CT scan and biopsy then revealed Natalie had Hodgkin Lymphoma - an uncommon cancer which develops in the lymphatic system. ‌ Natalie, who is a hairdresser, said: "Never in a million years did I think I'd be saying I had cancer at 34... I feel like the seat belt has probably factored in saving my life, which is strange. I'm really grateful for it. Things could've been very different for me. "People should be very vigilant over our bodies. Check yourself all the time. If you notice any sort of change and think that's not normal, get it checked out." ‌ Natalie had experienced no symptoms or changes in her health in the lead up to her cancer diagnosis, other than discovering the lump in her neck in her car. The mum, who is due to begin chemotherapy treatment, continued: "Life was normal. I had no symptoms, nothing. There were no changes in my body. I felt very fit and healthy. I didn't have any other symptoms. If I hadn't found the lump, I would've just carried on with life as normal. "I was on my way back from the supermarket after doing the weekly shop and I kept thinking the seatbelt was really irritating my neck. "I moved it away a few times and repositioned it but thought what is it doing? Then all of a sudden, I moved it away from me and touched my neck and felt this big mass in my neck. I just thought what on earth is that? I just remember the fear, anxiety and sickness that went through me." ‌ Cancer Research UK provide details on lymphoma The salon owner, of Nuneaton, Warwickshire, has stage-two Hodgkin Lymphoma. Around 2,100 people are diagnosed with Hodgkin lymphoma in the UK each year, according to the NHS. Typically, swelling in the neck, armpit or groin is an early sign of the cancer. This is caused by an excess of affected lymphocytes (white blood cells) collecting in a lymph node. But in Natalie's case, the lump was her first sign - and she is now imploring others to check their own bodies for any abnormal changes. She added: "I was thinking about my own funeral. It was awful to think that - I didn't think I'd be thinking about that until I was in my 80s. "We had so many wonderful things booked for this year but none of them can go ahead. My life has come to a standstill. How can you live your life normally, go shopping, find a lump and your whole life falls apart in that one second."

Patients to be fast-tracked on to new head and neck cancer vaccine trial
Patients to be fast-tracked on to new head and neck cancer vaccine trial

South Wales Argus

time2 hours ago

  • South Wales Argus

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'

Patients to be fast-tracked on to new head and neck cancer vaccine trial
Patients to be fast-tracked on to new head and neck cancer vaccine trial

Leader Live

time2 hours ago

  • Leader Live

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store